Simon Brack

576 total citations
12 papers, 444 citations indexed

About

Simon Brack is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Simon Brack has authored 12 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Simon Brack's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (5 papers) and Advanced Biosensing Techniques and Applications (3 papers). Simon Brack is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (5 papers) and Advanced Biosensing Techniques and Applications (3 papers). Simon Brack collaborates with scholars based in Switzerland, Sweden and Australia. Simon Brack's co-authors include Dario Neri, Michela Silacci, Manfred Birchler, Anna Ettorre, Adrian Merlo, Jessica Mårlind, Francesca Viti, Dragan Grabulovski, Julian Bertschinger and Kristina Klupsch and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Simon Brack

11 papers receiving 429 citations

Peers

Simon Brack
Manfred Birchler Switzerland
Roberto Sommavilla Switzerland
Jascha‐N. Rybak Switzerland
L. Zardi Switzerland
Anka Thies Germany
Jamie B. Andreyka United States
Diane Hahn Germany
T Yoneda Japan
Manfred Birchler Switzerland
Simon Brack
Citations per year, relative to Simon Brack Simon Brack (= 1×) peers Manfred Birchler

Countries citing papers authored by Simon Brack

Since Specialization
Citations

This map shows the geographic impact of Simon Brack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Brack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Brack more than expected).

Fields of papers citing papers by Simon Brack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Brack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Brack. The network helps show where Simon Brack may publish in the future.

Co-authorship network of co-authors of Simon Brack

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Brack. A scholar is included among the top collaborators of Simon Brack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Brack. Simon Brack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Klupsch, Kristina, Vanessa Baeriswyl, Roland W. Scholz, et al.. (2018). Abstract 1787: COVA4231, a potent CD3/CD33 bispecific FynomAb with IgG-like pharmacokinetics for the treatment of acute myeloid leukemia. Cancer Research. 78(13_Supplement). 1787–1787. 1 indexed citations
2.
Klupsch, Kristina, Fabian Buller, Roger Santimaria, et al.. (2015). Bispecific CD3/HER2 Targeting FynomAb Induces Redirected T Cell-Mediated Cytolysis with High Potency and Enhanced Tumor Selectivity. SHILAP Revista de lepidopterología. 4(4). 426–440. 21 indexed citations
3.
Brack, Simon, Babette Schade, Kristina Klupsch, et al.. (2014). A Bispecific HER2-Targeting FynomAb with Superior Antitumor Activity and Novel Mode of Action. Molecular Cancer Therapeutics. 13(8). 2030–2039. 34 indexed citations
4.
Woods, Richard, Simon Brack, Kristina Klupsch, et al.. (2014). Fynomer-antibody fusions targeting HER2 and CD3 for selective killing of HER2 overexpressing tumor cells.. Journal of Clinical Oncology. 32(15_suppl). 3066–3066.
5.
Schlatter, Daniel, Simon Brack, David W. Banner, et al.. (2012). Generation, characterization and structural data of chymase binding proteins based on the human Fyn kinase SH3 domain. mAbs. 4(4). 497–508. 32 indexed citations
6.
Toller, Isabella M., et al.. (2012). Bispecific Fynomer-antibody fusion proteins targeting two epitopes on HER2.. Journal of Clinical Oncology. 30(15_suppl). 2575–2575. 1 indexed citations
7.
Wunderlich, Heiko, Alexander Berndt, Mieczysław Gajda, et al.. (2008). A1 AND D DOMAIN OF TENASCIN C – NEW PROGNOSTIC MARKER IN BLADDER CANCER. The Journal of Urology. 179(4S). 315–315. 2 indexed citations
8.
Brack, Simon, Michela Silacci, Manfred Birchler, & Dario Neri. (2006). Tumor-Targeting Properties of Novel Antibodies Specific to the Large Isoform of Tenascin-C. Clinical Cancer Research. 12(10). 3200–3208. 153 indexed citations
9.
Berndt, Alexander, Petra Richter, Laura Borsi, et al.. (2006). Differential expression of tenascin-C splicing domains in urothelial carcinomas of the urinary bladder. Journal of Cancer Research and Clinical Oncology. 132(8). 537–546. 25 indexed citations
10.
Ettorre, Anna, Christoph Rösli, Michela Silacci, et al.. (2006). Recombinant antibodies for the depletion of abundant proteins from human serum. PROTEOMICS. 6(16). 4496–4505. 17 indexed citations
11.
Silacci, Michela, Simon Brack, Jessica Mårlind, et al.. (2005). Design, construction, and characterization of a large synthetic human antibody phage display library. PROTEOMICS. 5(9). 2340–2350. 146 indexed citations
12.
Dessi, P., Pavel F. Pavlov, Fredrik Wållberg, et al.. (2003). Investigations on the in vitro import ability of mitochondrial precursor proteins synthesized in wheat germ transcription-translation extract. Plant Molecular Biology. 52(2). 259–271. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026